Source: “11g poker chips” by Logan Ingalls from South Boston, MA, USA. Licensed under CC BY 2.0 via Wikimedia CommonsGive up now if you’re looking for a totally safe biotech stock. They don’t exist.But if you’re looking for a biotech stock that is relatively safe compared to most others, that’s a different story. And there’s one biotech that is arguably the […]
Momentum Stocks: Caution Ahead (Part 4 of 6)(Continued from Part 3)Another case in point is biotech.Biotech is another obvious example of the momentum trade. It is a high “beta” or risky industry that has been a strong relative performer for many years. Through the close of the week ended March 20, the Nasdaq Biotech Index had surged 20% year-to-date. The following […]
SAN FRANCISCO (MarketWatch)—Investors looking for early warnings signs of a shift in U.S. market sentiment would do well to watch tech and biotech stocks.That is because a selloff in those sectors is likely to signal that investors’ confidence in U.S. equities is deteriorating, according to Bank of America Merrill Lynch analyst Michael Hartnett“U.S. bear view requires [a] tech-wreck,” he writes […]
Source: Flickr user Mike PoreskyFew sectors offer a greater potential for risk and reward than biotechnology. It’s a sector where many companies are still in the early stages of their drug development process, but if you happen to catch a winner the returns can compound many times over.Unfortunately, the odds are stacked against biotech investors with far more drugs failing […]
See original article here:
Biotech ETFs in Focus after a Choppy Week – ETF News And Commentary
[…]
Since reaching all-time highs on March 19, the three largest biotech exchange traded funds are off 4.4% with the SPDR S&P Biotech ETF (XBI) ranking as the worst offender of the trio with a loss of 5.7%.XBI’s recent struggles illustrate the ETF’s risk/reward proposition. As an equal-weight ETF, the $2.1 billion XBI is dependent on the largest biotech stocks, such […]
About the AuthorMatt Coffina, CFA, is editor of Morningstar® StockInvestorSM.Contact Author | Meet other investing specialistsInterest Rates: Gravity for Asset Prices
Investors always hang on the Federal Reserve’s every word, but the obsession with monetary policy is reaching new heights as we approach the first short-term rate hike in almost a decade. The target federal funds rate has been around zero […]
In fact, biotech stocks have been so strong that “you could see these stocks off another 10 percent from here, and still be in an uptrend,” Johnson said. “We’d be buying these names on the pullback.”The fundamentals also remain supportive of biotech, says David Seaburg, head of equity sales trading with Cowen & Co.”From a valuation perspective, this is not […]
In fact, biotech stocks have been so strong that “you could see these stocks off another 10 percent from here, and still be in an uptrend,” Johnson said. “We’d be buying these names on the pullback.”The fundamentals also remain supportive of biotech, says David Seaburg, head of equity sales trading with Cowen & Co.”From a valuation perspective, this is not […]
Source: Ligand PharmaceuticalsHow hot is biotech these days? The top two exchange trade funds focusing on biotech stocks both more than tripled the performance of the S&P 500 index over the past 12 months. That’s pretty hot.You might be asking, however, if it’s too late to still make solid returns in this sizzling sector. Not at all. There are plenty […]
